MONTREAL--(BUSINESS WIRE)--The International Neuromodulation Society 12th World Congress takes place June 6 – 11 at the Fairmont Queen Elizabeth Hotel, with weekend events for the public, patients, and business community.
More than 1,500 researchers are expected at the main scientific congress, which covers neuromodulation therapy for chronic pain and ischaemia, Parkinson’s and other movement disorders, visceral problems such as bladder and bowel motility dysfunction, brain disorders such as epilepsy and psychiatric disorders.
Three special events occur the weekend of June 6 - 7:
1. On Saturday June 6, members of the investment community will hear from entrepreneurs and early–stage companies at an Innovations in Neuromodulation preconference.
2. The afternoon of June 6, the Canadian Neuromodulation Society offers a free public event “Neurostimulation & Patients”, hosted by journalist Bernard Derome, with talks by experts and patients from 12 – 16:30, preceded at 11 a.m. by a news briefing for the media.
To register for the free public lecture “Neurostimulation & Patients” on June 6, visit neurostimulation.eventbrite.com. (The talks are in English and French, with translation.)
3. On Sunday June 7, the daylong Mechanisms of Action preconference covers the basic science behind neuromodulation therapies.
Professionals may learn about or register for either International Neuromodulation Society preconference at www.neuromodulation.com/ins-congress.
Neuromodulation has been in common clinical use to manage chronic symptoms since the 1980s. The therapy is often accomplished through devices that deliver mild electrical impulses or micro-doses of medication to targeted sites in the body. Neuromodulation harnesses the body’s own tuning mechanisms to rebalance neural circuits and minimize the impact of disease states, such as chronic pain, Parkinson’s disease or other movement disorders, and bladder or bowel motility. Newer indications are being developed.
About the International Neuromodulation Society
The International Neuromodulation Society (INS) is a nonprofit medical society that unites clinicians, scientists and engineers to share scientific knowledge about all aspects of neuromodulation in order to encourage best medical practice. Founded in 1989 and based in San Francisco, CA, the INS presents up-to-date information about the full breadth of neuromodulation therapies through an interactive website at http://www.neuromodulation.com, chapter scientific meetings, the MEDLINE-indexed journal Neuromodulation: Technology at the Neural Interface, and its biennial world congress.